Funding · Company
Instylla, Inc.
Bedford, MABiotech & Pharma
Instylla, Inc. of Bedford, MA has disclosed $95M across 3 Form D offerings filed with the SEC between Nov 3, 2023 and Jul 28, 2026.
$95M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$35M
Form D · Jul 28, 2026 ↗
Q3 2026
· 1 amendment, first filed Oct 23, 2025
· target $35M
$30M
Form D · Nov 3, 2023 ↗
Q4 2023
· 1 amendment, first filed Aug 14, 2023
Filing details
HeadquartersBedford, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001708696Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →